MPMI (drug)

MPMI, also known as 3-(N-methylpyrrolidin-3-ylmethyl)indole or as N-methyl-α,N-trimethylenetryptamine, is a pyrrolidinylmethylindole and cyclized tryptamine which acts as a serotonin receptor agonist.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

MPMI, also known as 3-(N-methylpyrrolidin-3-ylmethyl)indole or as N-methyl-α,N-trimethylenetryptamine, is a pyrrolidinylmethylindole and cyclized tryptamine which acts as a serotonin receptor agonist. It has been studied as an analogue and trace impurity of the antimigraine drug eletriptan but is otherwise little known.

Analogues

Analogues of MPMI include 4-HO-MPMI, 5-MeO-MPMI, 5F-MPMI, eletriptan, CP-122288, CP-135807, 10,11-secoergoline (α,N-Pip-T), pyr-T, SN-22, and α,N,N-trimethyltryptamine, among others.

Canada

MPMI is not a controlled substance in Canada as of 2025.

United States

MPMI is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

Pyrrolidinylmethylindole Cyclized tryptamine

MPMI - Isomer Design

Text derived from https://en.wikipedia.org/w/index.php?oldid=1374432371 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.